Treatment of atrial flutter
6 results
1 - 6Atrial fibrillation recurrence higher with episodic treatment with amiodarone
Vitamin D and/or fish oil supplementation do not reduce the risk of atrial fibrillation (VITAL)
Warfarin provides greater net benefit than rivaroxaban for patients with atrial fibrillation and rheumatic heart disease
Rivaroxaban is noninferior to warfarin for valvular atrial fibrillation; also associated with fewer strokes
Direct oral anticoagulants associated with better outcomes than warfarin in older patients with stroke and AF (PROSPER)
Patent foramen ovale closure in cryptogenic stroke reduces recurrence rate compared with antiplatelet agents